The ER (endoplasmic reticulum) is the site of protein folding for all eukaryotic secreted and plasma membrane proteins. Disulphide bonds are formed in many of these proteins through a dithiol-disulphide exchange chain comprising two types of protein catalysts: PDI (protein disulphide-isomerase) and ERO (ER oxidoreductase) proteins. This review will examine what we know about ERO function, and will then consider ERO interactions and their implications for mammalian oxidative protein folding.
Defining the protein-protein interactions of the mammalian endoplasmic reticulum oxidoreductases (EROs)

Identification of EROs (endoplasmic reticulum oxidoreductases)
In eukaryotic cells, the ER (endoplasmic reticulum) provides an environment for secretory and outer membrane proteins to fold into their stable conformations with the assistance of various chaperone proteins and enzymes. One of the posttranslational modifications that confers structural stability and enzymatic function is the formation of disulphide bonds at the correct position during protein folding. With the discovery of yeast Ero1p [1, 2] , a redox pathway for transferring disulphide bonds to a newly synthesized protein was uncovered. This led to the identification of two hERO (human ERO) proteins, Ero1α and Ero1β [3, 4] . Both hEROs are capable of rescuing the Saccharomyces cerevisiae ero1-1 thermosensitive mutant and catalysing the oxidation of model substrates, indicating that these proteins are involved in disulphide bond formation.
A schematic diagram of the hEROs is shown in Figure 1 . Both hEROs have an N-terminal signal sequence that targets these proteins to the ER, where they are resident. Ero1α has two N-glycosylation sites, whereas Ero1β has four, although whether glycosylation affects protein function is yet unknown. Ero1α and Ero1β both have two conserved redoxactive motifs, a CXXXXC motif near the N-terminus and a CXXCXXC motif towards the C-terminus. Mutational and biochemical analysis of the yeast ERO1 gene has shown that the N-terminal active site cysteines are involved in a dithiol-disulphide exchange reaction with PDI (protein disulphide-isomerase; Figure 1C) . Accepted electrons are then transferred on to the C-terminal active site cysteines that then pass on electrons to molecular oxygen via FAD [5, 6] . The crystal structure of the yeast Ero1p core shows that the first (most N-terminal) cysteine in the CXXCXXC motif is involved in a long-range intramolecular disulphide bond, whereas the two more C-terminal cysteines (CXXCXXC) are redox active and are positioned for electron transfer to bound FAD [6a] .
ER retention of hEROs
S. cerevisiae Ero1p has a C-terminal tail of 127 amino acid residues that enables this protein to be localized in the ER [7] . hEROs lack this C-terminal tail and do not have a conventional KDEL ER retention/retrieval sequence. So how are the soluble hEROs retained in the ER lumen? Biochemical analysis has shown that hEROs are closely associated with ER membranes [4] and more recently Ero1α has been found in mixed disulphide complexes with ERp44. ERp44 is a relative of PDI, and interactions with both ERp44 and PDI are likely to contribute to ER retention of hEROs indirectly, by virtue of their partner protein's KDEL (or RDEL) motif [8, 9] .
Ero1α and Ero1β regulation
Although Ero1α and Ero1β have many similar biochemical properties, there are some important differences between them. Ero1β transcript expression can be induced chemically by preventing N-glycosylation and disulphide bond formation, both of which trigger the UPR (unfolded protein response) [4] . Ero1α, on the other hand, is regulated by cellular oxygen tension [10] . Recent evidence examining the secreted proangiogenesis factor VEGF (vascular endothelial growth factor) showed that Ero1α is involved in a HIF-l (hypoxia inducible factor-1)-mediated pathway used to induce protein secretion under hypoxic conditions. Targeting Ero1α expression in tumour cells might therefore be a potential therapeutic target for future cancer therapies [11] . At the mRNA level, Ero1α and Ero1β transcripts also display differential tissue expression, with Ero1α transcripts abundant in the oesophagus, compared with the pancreas, stomach, testis and pituitary glands, where Ero1β is strongly expressed [4] . However, the expression of Ero1β at the protein level and the requirement for induction by UPR in vivo has remained unknown. We have therefore investigated the expression of Ero1β proteins in secretory tissues, including the stomach and pancreas.
Tissue-specific Ero1β expression
Using immunohistochemistry, we have shown that in human stomach, Ero1β and PDI, along with other ER chaperones, are highly expressed in enzyme-secreting chief cells. In contrast, in the human pancreas, Ero1β and PDI expression are not strictly correlated. Ero1β is expressed in both exocrine (acinar) and endocrine (islet) cells, compared with the mostly exocrine expression of PDI and its pancreas-specific sister PDIp [12] . Clearly the control of disulphide bond formation in vivo is more complicated than we first imagined in mammals, with Ero1β expression constitutively and strongly switched on in at least some secretory tissues. Not only is Ero1β expression tissue-specific, there are also cell-specific differences in expression within a tissue. These results prompted us to look in more detail at the types of interactions that hEROs could facilitate in the ER.
hERO interactions
We and others have shown that both Ero1α and Ero1β interact with PDI in a disulphide-and alkylation-dependent manner [12, 13] . Using mutational studies of the hERO C-terminal active site, it has been shown that an AXXCXXC hERO mutant interacts poorly with PDI. This is probably due to disruption of the long-range intramolecular disulphide bond that alters structural elements of the Ero protein. CXXAXXC and CXXCXXA mutants remain capable of binding to PDI, but are enzymatically crippled by the loss of their redox-active cysteines residues. However, Ero1β is also able to form alkylation-independent complexes and these interactions were investigated using differentially tagged Ero1β constructs [12] . A notable proportion of Ero1β exists as a homodimeric pool at steady state and mutating Cys 396 (CXXCXXA) prevents homodimer formation. In addition, Ero1α and Ero1β are able to form mixed dimers. Using the crystal contact details from the Ero1p monomer [14] a symmetrical dimer was modelled in which FAD contributes up to 20% of the dimer interface [12] . Although the Cys 396 residue is buried too deeply within the Ero monomer to form an intermolecular disulphide bond, its close proximity to FAD suggests that the mutation might disrupt FAD binding. This probably leads to collapse of the FAD-FAD interface and prevention of dimerization.
hERO dimers and their possible function
What could be the significance of dimer formation for hERO function? A dimer might protect non-specific proteins from oxidative damage by spent electrons, particularly since Eroβ is highly expressed in secretory tissues. If left unregulated, electron transfer to EROs could result in the generation of reactive oxygen species and oxidative stress. Alternatively, hERO dimers could also be used for the storage of oxidizing power in tissues with intermittent secretory demands, thus allowing for rapid mobilization of disulphide bond donors. However, it would be unexpected for a tissue to switch on protein expression via the UPR and then store that protein in an inactive form. A third possibility is that hERO dimers form part of a larger oxidation complex. The dimer interface probably does not preclude PDI binding, so it is possible that PDI-ERO-ERO-PDI tetramers are brought together to facilitate efficient oxidative protein folding in the ER. Addressing the true physiological function of hERO dimers is not trivial, and will require a combination of in vitro assays and site-directed mutagenesis, as well as the generation of tissue-specific knockout and knockin mice. The ER still has much more to tell us about how disulphide bond formation and protein secretion are organized and regulated in complex animals.
